| ABCELLERA BIOLOGICS |
| Kanada |
| Gesundheit |
| CA00288U1066 / A2QKXS |
| 8QQ (Frankfurt) / ABCL (NASDAQ) |
| FRA:8QQ, ETR:8QQ, 8QQ:GR, NASDAQ:ABCL |
| - |
| https://www.abcellera.com.. |
|
AbCellera Biologics Inc. is a clinical-stage biotechnology company focused on discovering and developing antibody-based medicines. Its platform combines biology, computation, engineering, and data science to identify rare and potent antibodies from n..
>Volltext.. |
| 3977.76 Mio. EUR |
| 3600.75 Mio. EUR |
| 58.35 Mio. EUR |
| -169.81 Mio. EUR |
| -145.2 Mio. EUR |
| -0.48 EUR |
| 119.59 Mio. EUR |
| 127.92 Mio. EUR |
| -83.25 Mio. EUR |
| 10.62 |
| 107.61% |
| -2.52% |
| - |
| - |
| - |
| - |
| ABCELLERA |
| 30.09.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|